While AS has been documented in various tumors [7], the regulatory mechanisms of AS in β-arrestin1 (ARRB1) that contribute to malignant phenotypes in GBM, including invasiveness, growth and aberrant metabolism remain poorly understood [8]. Here, ARRB1 is linked to glioblastoma.